Are These Stocks Facing Difficult Challenges? MannKind Corporation (MNKD), Halcon Resources Corp (HK) and Novovax Inc (NVAX)

Posted by Saimoon March 24, 2015 0 Comment 1093 views


New York, NY – GDP INSIDER  –  03/24/2015.

This articles discusses three companies: MannKind Corporation (NASDAQ:MNKD), Halcon Resources Corp (NYSE:HK) and Novovax Inc (NASDAQ:NVAX)

MannKind Corporation (NASDAQ:MNKD) continued to decline yesterday with the stock losing 0.76% or $0.04 to close at $5.22 on light trading of 3.371 million shares, compared to its three month average trading volume of 5.680 million. The biopharmaceutical company focused on treatments for diabetes and cancer has been struggling for the last month, with the stock down 22.32% from its high point of $7.00. With bullish converging MACD and RSI of 31.39 the stock is starting to look undervalued and could be a good buy for the medium term, definitely worth holding now.

Does MannKind Corporation Have The Resources The Recover? Delve Into The Details With Free MNKD Analysis.

Halcon Resources Corp (NYSE:HK) fell back again yesterday after climbing slightly on Friday, with the stock declining 2.5% or $0.04 to close at $1.56 on very active trading of 5.307 million shares, compared to its three month average trading volume of 4.836 million. The independent liquid rich oil and natural gas developer has been particularly hard hit by the ongoing decline in oil prices and is now down 12.35% so far this year, compared to the S&P 500 which is up 2.20% for the same period. Until oil prices recover it is better to sell than to hold.

Can Halcon Resources Corp’s Finances Support Further Oil Price Drops? Click Here For Free HK Analysis.

Novovax Inc (NASDAQ:NVAX) retreated slightly yesterday to close down 0.31% or $0.03 with more than 2.995 million shares changing hands, compared to its three month average trading volume of 5.226 million. The infectious disease clinical stage biopharmaceutical company is enjoying solid gains so far this year, with the share price up 61.04% as investors move out of oil and related commodities into the medical research sector. With the MACD now starting to diverge downwards and RSI of 66.51, the stock looks like it is trading near the top of its range, making it a hold at best for now.

Is Novovax Inc’s Current Trend A True Indicator Of Its Value? Get The Complete Picture with Free NVAX Analysis.

About UltimateStockAlerts

UltimateStockAlerts.com provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word ULTIMATE to 555888 from your cell phone.

UltimateStockAlerts continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.

Disclosure:  UltimateStockAlerts is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit www.UltimateStockAlerts.com website, for complete risks and disclosures.


Write Your Comment